medpagetoday.com posted a brief but concise article earlier this week on the issue of FDA regulating laboratory developed tests (LDTs). While the FDA has had the ability to regulate these tests since 1976, largely once regarded as "simple and...

Courtesy of STAT By Linnea Olson and Michael MisialekAwesome read about a patient and pathologist exploring lung cancer together. Patients can be their own best advocates while pathologists should have the opportunity to meet their patients....

Jessica is a 42-year old wife and mother of 2. She was diagnosed with an aggressive form of breast cancer just over seven years ago and doctors recently declared her with no evidence of disease. As a young woman with breast cancer, she became...

A recent news brief service recently sent out highlights about a new study published in NEJM that questions the value of mammography for breast cancer screening while critics cited in the news brief call the study "deeply flawed" and suggest...

Many of you have already been contacted about this in the past few months. Perhaps repeatedly. Through this site, emails, in-person and/or by phone.  And many of you have generously supported these rides and organization. Time is close for the...

When serum protein biomarker data were used independently, clinical sensitivity and specificity for detection of breast cancer were 74.7% and 77.0%, respectively. When tumor-associated autoantibody data were used independently,...